Prostate Cancer - Results from #380

WHO Classification of Tumours 5th Edition: Evolving Issues in Classification, Diagnosis and Prognostication of Prostate Cancer. June 30, 2022

Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer. June 29, 2022

Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant Tissue. June 29, 2022

Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence. June 29, 2022

Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer. June 29, 2022

Does testosterone mediate the relationship between vitamin D and prostate cancer progression? A systematic review and meta-analysis. June 29, 2022

Effects of a multicomponent resistance-based exercise program with protein, vitamin D and calcium supplementation on cognition in men with prostate cancer treated with ADT: secondary analysis of a 12-month randomised controlled trial. June 28, 2022

Safety and efficacy of MRI-guided transurethral ultrasound ablation for radiorecurrent prostate cancer in the presence of gold fiducial markers. June 28, 2022

Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib: Results from TALAPRO-1. June 28, 2022

Development of a novel nomogram to identify the candidate to extended pelvic lymph node dissection in patients who underwent mpMRI and target biopsy only. June 28, 2022

Skeletal-related events after abiraterone or enzalutamide in patients with metastatic castration-resistant prostate cancer: A population-based study using the SEER-Medicare linked dataset. June 28, 2022

Changes in prostate cancer survival among insured patients in relation to USPSTF screening recommendations. June 28, 2022

New Aetna Policy for PSMA Screening for PLUVICTO Radioligand Therapy June 27, 2022

Statins and prostate cancer-hype or hope? The epidemiological perspective. June 27, 2022

Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601. June 27, 2022

Web-Based Peer Navigation for Men with Prostate Cancer and Their Family Caregivers: A Pilot Feasibility Study. June 27, 2022

A Case Study of Clinical Response to Rucaparib in a Patient with Metastatic Castration-Resistant Prostate Cancer and a RAD51B Alteration. June 27, 2022

Predictive role of node-rads score in patients with prostate cancer candidates for radical prostatectomy with extended lymph node dissection: comparative analysis with validated nomograms. June 27, 2022

Up-regulation of POM121 is linked to prostate cancer aggressiveness and serves as a prognostic biomarker. June 24, 2022

Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men. June 24, 2022

Page 20 of 1250

email news signup